Bifidobacterium animalis subsp. lactis – BS07 (MB 243)
Cardiovascular health • Cholesterol lowering
Cholesterol management
Bifidobacterium bifidum – BB06 (MB 107)
Cardiovascular health • Cholesterol lowering
Bifidobacterium bifidum – MB109 (DSM 23731)
Cardiovascular health • Cholesterol lowering
Bifidobacterium breve – MB113 (DSM 23732)
Cardiovascular health • Cholesterol lowering
Bifidobacterium infantis – BI02 (DSM 24687, formerly MB287)
Cardiovascular health • Cholesterol lowering
Bifidobacterium lactis – MB2409 (DSM 23733)
Cardiovascular health • Cholesterol lowering
Bifidobacterium longum – 04 (DSM 23233)
Restoration of a better dietary ω-6/ω-3 balance • Conjugated linoleic acids (CLA) production • Prospective use in the treatment of obesity • Cholesterol management
MetSyn
MetSyn is a probiotic complex by SynBalance, specifically designed for metabolic syndrome.It has been tested in a randomized, double-blind, controlled clinical trial on 60 subjects diagnosed with metabolic syndrome. After 14 days of run-in, in which subjects were asked to improve their lifestyle, the probiotic and placebo supplements were administered for 2 months. Patients were …
Lactobacillus fermentum – ME-3 (DSM 14241)
Under license from the University of Tartu for food applications Cardiovascular health • LDL-cholesterol lowering • Antioxidant properties
Lactobacillus salivarius I 1794
Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at …
Lactobacillus paracasei I 1688
Restoration of the physiological intestinal balance. Pediatric gastroenteritis. Immunomodulatory activity in allergic patients (for asthma and allergic rhinitis). Induces a significant reduction of LDL cholesterol, as well as a significant improvement of the LDL / HDL ratio. Reduces the release of type 2 cytokines, induces an improvement in the th1 / th2 ratio. Deposited at …
Lacticaseibacillus rhamnosus HA-114
L. rhamnosus HA-114 is an innovative patent-pending probiotic strain able to improve eating and mood-related behaviors in overweight adults undergoing a diet-induced weight loss. It could favor wellness and facilitate adherence during a diet-based weight reduction program, through its action on the brain-gut axis. L. rhamnosus HA-114 supports weight management efforts during a diet (eating …
Lactobacillus helveticus Lafti® L10
L. helveticus Lafti® L10 has been documented on athletes’ population specifically to answer their needs in immune health. Sport induces a physiological stress and can significantly impair natural defenses. Lafti® L10 helps over trained athletes to recover an effective immune system similar to healthy athletes by increasing IFN-γ levels, a biomarker for natural defenses (p=0.01) as …
Limosilactobacillus reuteri PBS072 (DSM 25175)
Limosilactobacillus reuteri PBS072 (DSM 25175), developed by SynBalance.Gastrointestinal Health • Urogenital health • Cognitive function • Metabolic Health • Skin Health
Lactobacillus gasseri LG050
Lactobacillus gasseri LG050 (LMG P-29638), developed by SynBalanceGastrointestinal Health • Urogenital health • Metabolic Health
